Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women

Ana Rodriguez, Kathleen M. Schmeler, Yong Fang Kuo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective. To compare demographics, tumor characteristics, the first course of treatment, and cancer-specific survival of non-Hispanic White and Hispanic women with endometrial cancer. Methods. We used public-use data from the Surveillance, Epidemiology, and End Results (SEER) Program. The study included 69,764 non-Hispanic White and Hispanic women diagnosed with endometrial cancer between 2000 and 2010. Using Cox proportional hazards models, demographics, tumor characteristics, and treatment were assessed as potential explanatory variables for the survival disparity between non-Hispanic Whites and Hispanics. Results. Kaplan-Meier estimation with Bonferroni correction showed statistically different cancer-specific survival for U.S.-born and foreign-born Hispanics compared to non-Hispanic Whites, but no difference between birthplace-unknown Hispanics and non-Hispanic Whites. In 2000-2005, U.S.-born and foreign-born Hispanics had a higher risk of endometrial cancer death compared to non-Hispanic Whites after full adjustment (hazard rate (HR) = 1.61, 95% Confidence Interval (CI):1.44-1.79 and 1.27, 95% CI:1.13-1.43). In 2006-2010, the risk of endometrial death was not statistically significant for U.S.-born Hispanics (HR = 1.16, 95% CI:0.99-1.36), but increased for foreign-born Hispanics (HR = 1.31, 95% CI:1.12-1.52). Most of the survival disparity between Hispanic and non-Hispanic White women was mediated by cancer characteristics, specifically, stage and node involvement. Conclusions. Hispanic women have higher cancer-specific mortality compared to non-Hispanic Whites. Compared to 2000-2005, more Hispanics were diagnosed at later stages and fewer received combination therapy in 2006-2010. Early detection is vital to improving endometrial cancer survival as most of the disparity was mediated by stage. Increased efforts are needed to improve education and access to care for Hispanic women.

Original languageEnglish (US)
Pages (from-to)525-533
Number of pages9
JournalGynecologic Oncology
Volume135
Issue number3
DOIs
StatePublished - Dec 1 2014

Fingerprint

Endometrial Neoplasms
Hispanic Americans
Survival
Confidence Intervals
Neoplasms
Demography
SEER Program
Proportional Hazards Models
Therapeutics
Education

Keywords

  • Endometrial cancer
  • Hispanics
  • Non-Hispanic Whites
  • SEER

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology
  • Medicine(all)

Cite this

Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women. / Rodriguez, Ana; Schmeler, Kathleen M.; Kuo, Yong Fang.

In: Gynecologic Oncology, Vol. 135, No. 3, 01.12.2014, p. 525-533.

Research output: Contribution to journalArticle

@article{4ec56d774c2f4a6f8b9aff4ed4defb4b,
title = "Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women",
abstract = "Objective. To compare demographics, tumor characteristics, the first course of treatment, and cancer-specific survival of non-Hispanic White and Hispanic women with endometrial cancer. Methods. We used public-use data from the Surveillance, Epidemiology, and End Results (SEER) Program. The study included 69,764 non-Hispanic White and Hispanic women diagnosed with endometrial cancer between 2000 and 2010. Using Cox proportional hazards models, demographics, tumor characteristics, and treatment were assessed as potential explanatory variables for the survival disparity between non-Hispanic Whites and Hispanics. Results. Kaplan-Meier estimation with Bonferroni correction showed statistically different cancer-specific survival for U.S.-born and foreign-born Hispanics compared to non-Hispanic Whites, but no difference between birthplace-unknown Hispanics and non-Hispanic Whites. In 2000-2005, U.S.-born and foreign-born Hispanics had a higher risk of endometrial cancer death compared to non-Hispanic Whites after full adjustment (hazard rate (HR) = 1.61, 95{\%} Confidence Interval (CI):1.44-1.79 and 1.27, 95{\%} CI:1.13-1.43). In 2006-2010, the risk of endometrial death was not statistically significant for U.S.-born Hispanics (HR = 1.16, 95{\%} CI:0.99-1.36), but increased for foreign-born Hispanics (HR = 1.31, 95{\%} CI:1.12-1.52). Most of the survival disparity between Hispanic and non-Hispanic White women was mediated by cancer characteristics, specifically, stage and node involvement. Conclusions. Hispanic women have higher cancer-specific mortality compared to non-Hispanic Whites. Compared to 2000-2005, more Hispanics were diagnosed at later stages and fewer received combination therapy in 2006-2010. Early detection is vital to improving endometrial cancer survival as most of the disparity was mediated by stage. Increased efforts are needed to improve education and access to care for Hispanic women.",
keywords = "Endometrial cancer, Hispanics, Non-Hispanic Whites, SEER",
author = "Ana Rodriguez and Schmeler, {Kathleen M.} and Kuo, {Yong Fang}",
year = "2014",
month = "12",
day = "1",
doi = "10.1016/j.ygyno.2014.10.021",
language = "English (US)",
volume = "135",
pages = "525--533",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women

AU - Rodriguez, Ana

AU - Schmeler, Kathleen M.

AU - Kuo, Yong Fang

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Objective. To compare demographics, tumor characteristics, the first course of treatment, and cancer-specific survival of non-Hispanic White and Hispanic women with endometrial cancer. Methods. We used public-use data from the Surveillance, Epidemiology, and End Results (SEER) Program. The study included 69,764 non-Hispanic White and Hispanic women diagnosed with endometrial cancer between 2000 and 2010. Using Cox proportional hazards models, demographics, tumor characteristics, and treatment were assessed as potential explanatory variables for the survival disparity between non-Hispanic Whites and Hispanics. Results. Kaplan-Meier estimation with Bonferroni correction showed statistically different cancer-specific survival for U.S.-born and foreign-born Hispanics compared to non-Hispanic Whites, but no difference between birthplace-unknown Hispanics and non-Hispanic Whites. In 2000-2005, U.S.-born and foreign-born Hispanics had a higher risk of endometrial cancer death compared to non-Hispanic Whites after full adjustment (hazard rate (HR) = 1.61, 95% Confidence Interval (CI):1.44-1.79 and 1.27, 95% CI:1.13-1.43). In 2006-2010, the risk of endometrial death was not statistically significant for U.S.-born Hispanics (HR = 1.16, 95% CI:0.99-1.36), but increased for foreign-born Hispanics (HR = 1.31, 95% CI:1.12-1.52). Most of the survival disparity between Hispanic and non-Hispanic White women was mediated by cancer characteristics, specifically, stage and node involvement. Conclusions. Hispanic women have higher cancer-specific mortality compared to non-Hispanic Whites. Compared to 2000-2005, more Hispanics were diagnosed at later stages and fewer received combination therapy in 2006-2010. Early detection is vital to improving endometrial cancer survival as most of the disparity was mediated by stage. Increased efforts are needed to improve education and access to care for Hispanic women.

AB - Objective. To compare demographics, tumor characteristics, the first course of treatment, and cancer-specific survival of non-Hispanic White and Hispanic women with endometrial cancer. Methods. We used public-use data from the Surveillance, Epidemiology, and End Results (SEER) Program. The study included 69,764 non-Hispanic White and Hispanic women diagnosed with endometrial cancer between 2000 and 2010. Using Cox proportional hazards models, demographics, tumor characteristics, and treatment were assessed as potential explanatory variables for the survival disparity between non-Hispanic Whites and Hispanics. Results. Kaplan-Meier estimation with Bonferroni correction showed statistically different cancer-specific survival for U.S.-born and foreign-born Hispanics compared to non-Hispanic Whites, but no difference between birthplace-unknown Hispanics and non-Hispanic Whites. In 2000-2005, U.S.-born and foreign-born Hispanics had a higher risk of endometrial cancer death compared to non-Hispanic Whites after full adjustment (hazard rate (HR) = 1.61, 95% Confidence Interval (CI):1.44-1.79 and 1.27, 95% CI:1.13-1.43). In 2006-2010, the risk of endometrial death was not statistically significant for U.S.-born Hispanics (HR = 1.16, 95% CI:0.99-1.36), but increased for foreign-born Hispanics (HR = 1.31, 95% CI:1.12-1.52). Most of the survival disparity between Hispanic and non-Hispanic White women was mediated by cancer characteristics, specifically, stage and node involvement. Conclusions. Hispanic women have higher cancer-specific mortality compared to non-Hispanic Whites. Compared to 2000-2005, more Hispanics were diagnosed at later stages and fewer received combination therapy in 2006-2010. Early detection is vital to improving endometrial cancer survival as most of the disparity was mediated by stage. Increased efforts are needed to improve education and access to care for Hispanic women.

KW - Endometrial cancer

KW - Hispanics

KW - Non-Hispanic Whites

KW - SEER

UR - http://www.scopus.com/inward/record.url?scp=84920747251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920747251&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2014.10.021

DO - 10.1016/j.ygyno.2014.10.021

M3 - Article

VL - 135

SP - 525

EP - 533

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -